Picture of Cosmo Bio logo

3386 — Cosmo Bio News Story

0.000.00%
jp flag iconLast trade - 00:00
HealthcareConservativeMicro CapContrarian

Table: Cosmo Bio -2020 group results

Feb 12 (Reuters)- 
          Cosmo Bio Co Ltd 
          CONSOLIDATED FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)
                 Year ended      Year ended       Year to       NEXT   
              Dec 31, 2020    Dec 31, 2019   Dec 31, 2021     YEAR     
                 LATEST         YEAR-AGO        COMPANY      COMPANY   
                 RESULTS         RESULTS       FORECAST    H1 FORECAST 
  Sales           8.09            7.59           8.20          4.00    
               (+6.6 pct)      (+4.5 pct)     (+1.3 pct)    (+1.4 pct) 
  Operating      752 mln         405 mln        700 mln      370 mln   
               (+85.6 pct)     (+23.5 pct)    (-7.0 pct)   (-14.3 pct) 
  Recurring      817 mln         470 mln        750 mln      410 mln   
               (+73.7 pct)     (+16.5 pct)    (-8.3 pct)   (-15.0 pct) 
  Net
  Net            674 mln         237 mln        480 mln      260 mln   
              (+183.2 pct)     (-8.6 pct)     (-28.8 pct)  (-42.3 pct) 
  EPS          113.70 yen       40.14 yen      80.97 yen    43.86 yen  
  Ann Div       34.00 yen       14.00 yen      26.00 yen               
  -Q2 Div       8.00 yen        6.00 yen       12.00 yen               
  -Q4 Div       26.00 yen       8.00 yen       14.00 yen               
  
  NOTE - Cosmo Bio Co Ltd.
  *Second Net profit row denotes profit attributable to owners ofthe parent 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=3386.T

Recent news on Cosmo Bio

See all news